CAS: 1380341-99-0
Ref: IN-DA009Z01
5mg | 159.00 € | ||
10mg | 183.00 € | ||
25mg | 267.00 € | ||
50mg | 497.00 € | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 13 Dec 2024
Ref: 4Z-G-219002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 20 Dec 2024
Ref: 4Z-G-219001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 20 Dec 2024
GAL-021
CAS:1380341-99-0
GAL-021 an intravenous BKCa-channel blocker.
Formula:
C11H22N6O
Purity:
97.71% - 99.73%
Color and Shape:
Solid
Molecular weight:
254.33
Ref: TM-T3557
1mg | 36.00 € | ||
5mg | 73.00 € | ||
10mg | 101.00 € | ||
25mg | 183.00 € | ||
50mg | 276.00 € | ||
100mg | 426.00 € | ||
500mg | 916.00 € | ||
1mL*10mM (DMSO) | 83.00 € |
Estimated delivery in United States, on Friday 20 Dec 2024
N2-Methoxy-N2-methyl-N4,N6-dipropyl-1,3,5-triazine-2,4,6-triamine or ENA-001
Controlled ProductCAS:1380341-99-0
Formula:
C11H22N6O
Color and Shape:
Neat
Molecular weight:
254.34
Ref: TR-M563780
250mg | 1,050.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
GAL-021
CAS:1380341-99-0
GAL-021 is an orally active compound that is being developed for the treatment of inflammatory …
Formula:
C11H22N6O
Purity:
Min. 95%
Molecular weight:
254.33 g/mol
Ref: 3D-FFC34199
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 24 Jan 2025